First-half 2014 medtech acquisition values surpasses 2013 in total

First-half medtech acquisition value surpasses 2013 total  (EP Vantage)

Source
EP Vantage

Company
Thermo Fisher Scientific, Abbott Laboratories, Ansell, Bausch + Lomb, Baxter International, Bayer, bioMérieux, Cardinal Health, CareFusion, Covidien, Essilor International, Grifols, Illumina, Johnson & Johnson, Kinetic Concepts, Medtronic, MicroPort Scientific, Novartis, Smith & Nephew, Stryker, Valeant Pharmaceuticals International

Tags
Analysis, Company Strategy, Medtech, Subsidiary, Disposal, Acquisition, Merger, Free Content

Date
July 22, 2014

Large medtech companies seem t...